Oral L-arginine aspartate administration — Competitive Intelligence Brief

Oral L-arginine aspartate administration (Oral L-arginine aspartate administration) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino acid supplement / Nitric oxide donor. Area: Cardiovascular.

phase 3 Amino acid supplement / Nitric oxide donor Nitric oxide synthase (NOS) Cardiovascular Small molecule

Target snapshot

Oral L-arginine aspartate administration (Oral L-arginine aspartate administration) — Ukrainian Medical Stomatological Academy. L-arginine aspartate is a nitric oxide precursor that enhances endothelial function and vascular reactivity through increased NO production.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Oral L-arginine aspartate administration TARGET	Oral L-arginine aspartate administration	Ukrainian Medical Stomatological Academy	phase 3	Amino acid supplement / Nitric oxide donor	Nitric oxide synthase (NOS)
L-arginine + heme arginate	L-arginine + heme arginate	Radboud University Medical Center	marketed	Amino acid supplement / Nitric oxide donor	Nitric oxide synthase (NOS); hemoglobin

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amino acid supplement / Nitric oxide donor class)

1. Radboud University Medical Center · 1 drug in this class
2. Ukrainian Medical Stomatological Academy · 1 drug in this class